Author: Böhler Steffen Pittrow David Bramlage Peter Kirch Wilhelm
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.4, Iss.1, 2005-01, pp. : 7-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Angiotensin receptor blockers and drug–drug interactions
Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. :
Vascular benefits of angiotensin receptor blockers
Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-06 ,pp. :
Angiotensin Receptor Blockers and the Risk of Malignancy: A Note of Caution
Drug Safety, Vol. 33, Iss. 9, 2010-09 ,pp. :